Although only selected myosin genes were included in the OOM profiling, they featured as dysregulated genes (Figs. 2, 4), and underscore the previous hypothesis based on clinical and histopathological reports in MG muscles, that loss of muscle contractility is critical in driving OP-MG pathogenesis [19, 45]. This evidence concerns the gene MYH14 and myasthenia gravis.